The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases
Open accessAbstract
Innate immunity represents the semi-specific first line of defense and provides the initial host response to tissue injury, trauma, and pathogens. Innate immunity activates the adaptive immunity, and both act highly regulated together to establish and maintain tissue homeostasis. Any dysregulation of this interaction can result in chronic inflammation and autoimmunity and is thought to be a major underlying cause in the initiation and progression of highly prevalent immune-mediated inflammatory diseases (IMIDs) such as psoriasis, rheumatoid arthritis, inflammatory bowel diseases among others, and periodontitis. Th1 and Th2 cells of the adaptive immune system are the major players in the pathogenesis of IMIDs. In addition, Th17 cells, their key cytokine IL-17, and IL-23 seem to play pivotal roles. This review aims to provide an overview of the current knowledge about the differentiation of Th17 cells and the role of the IL-17/IL-23 axis in the pathogenesis of IMIDs. Moreover, it aims to review the association of these IMIDs with periodontitis and briefly discusses the therapeutic potential of agents that modulate the IL-17/IL-23 axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 1×
“IL-6 in mice and IL-1β in humans (Figure 1c,d) [33,34].”
BackgroundDifferentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,021
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60150-0 · Cited by 2,078
Periodontitis and diabetes: a two-way relationship
Preshaw, P. M., Alba, A. L., Herrera, D., Jepsen, S., Konstantinidis, A., Makrilakis, K., & Taylor, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2342-y · Cited by 1,877
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,848
Fox, R. I. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66990-5 · Cited by 1,828
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Guo, Q., Wang, Y., Xu, D., Nossent, J., Pavlos, N. J., & Xu, J. (2018) · Bone Research · doi:10.1038/s41413-018-0016-9 · Cited by 1,767
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,507
Inflammatory and immune pathways in the pathogenesis of periodontal disease
Cekici, A., Kantarci, A., Hasturk, H., & Van Dyke, T. E. (2014) · Periodontology 2000 · doi:10.1111/prd.12002 · Cited by 1,415 · cited 2×
“In periodontitis, however, a dysbiotic oral microbiome is known to contribute to the disease onset and progression [11].”
BackgroundPapp, K. A., Langley, R. G., Lebwohl, M., Krueger, G. G., Szapary, P., Yeilding, N., Guzzo, C., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,361
Immunopathogenesis of Rheumatoid Arthritis
Firestein, G. S., & McInnes, I. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.006 · Cited by 1,301
Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice
Nakae, S., Nambu, A., Sudo, K., & Iwakura, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6173 · Cited by 1,273
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Fate mapping of IL-17-producing T cells in inflammatory responses
Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. (2011) · Nature Immunology · doi:10.1038/ni.1993 · Cited by 1,176
Induction and molecular signature of pathogenic TH17 cells
Lee, Y., Awasthi, A., Yosef, N., Quintana, F. J., Xiao, S., Peters, A., Wu, C., Kleinewietfeld, M., Kunder, S., Hafler, D. A., et al. (2012) · Nature Immunology · doi:10.1038/ni.2416 · Cited by 1,174
A Validated Regulatory Network for Th17 Cell Specification
Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A., Huang, W., Parkurst, C. N., Muratet, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.016 · Cited by 1,160
Psoriasis and comorbid diseases
Takeshita, J., Grewal, S., Langan, S. M., Mehta, N. N., Ogdie, A., Van Voorhees, A. S., & Gelfand, J. M. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.07.064 · Cited by 1,145
The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
Di Cesare, A., Di Meglio, P., & Nestle, F. O. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.59 · Cited by 1,129
The IL-23/IL-17 axis in inflammation
Iwakura, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28508 · Cited by 1,046
Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., & Fathman, C. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.5 · Cited by 989
Cytokines in acute and chronic inflammation
Wright, T. M. (1997) · Frontiers in Bioscience · doi:10.2741/a171 · Cited by 963
Hirota, K., Yoshitomi, H., Hashimoto, M., Maeda, S., Teradaira, S., Sugimoto, N., Yamaguchi, T., Nomura, T., Ito, H., Nakamura, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071397 · Cited by 937
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C., Xia, Y., Zhou, B., Li, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0810652 · Cited by 859
T-cell subsets (Th1 versus Th2)
Romagnani, S. (2000) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62426-x · Cited by 815
The development of inflammatory TH-17 cells requires interferon-regulatory factor 4
Brüstle, A., Heink, S., Huber, M., Rosenplänter, C., Stadelmann, C., Yu, P., Arpaia, E., Mak, T. W., Kamradt, T., & Lohoff, M. (2007) · Nature Immunology · doi:10.1038/ni1500 · Cited by 692
Nicholson, L. B. (2016) · Essays in Biochemistry · doi:10.1042/ebc20160017 · Cited by 623
Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox
Rubartelli, A., & Lotze, M. T. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.08.004 · Cited by 614 · cited 1×
“Moreover, it promotes phagocytosis, and activates the complement and adaptive immune system [2].”
BackgroundIL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease
Kobayashi, T., Okamoto, S., Hisamatsu, T., Kamada, N., Chinen, H., Saito, R., Kitazume, M. T., Nakazawa, A., Sugita, A., Koganei, K., et al. (2008) · Gut · doi:10.1136/gut.2007.135053 · Cited by 570
Crohn Disease: Epidemiology, Diagnosis, and Management
Feuerstein, J. D., & Cheifetz, A. S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.04.010 · Cited by 548
Psoriasis pathophysiology: current concepts of pathogenesis
Krueger, J. G., & Bowcock, A. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.031120 · Cited by 523
Romagnani, S. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199911000-00009 · Cited by 520
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
Ogawa, A., Andoh, A., Araki, Y., Bamba, T., & Fujiyama, Y. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.09.013 · Cited by 495
Hirota, K., Hashimoto, M., Yoshitomi, H., Tanaka, S., Nomura, T., Yamaguchi, T., Iwakura, Y., Sakaguchi, N., & Sakaguchi, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062259 · Cited by 482
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
Basic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 470
Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
Moulton, V. R., Suarez-Fueyo, A., Meidan, E., Li, H., Mizui, M., & Tsokos, G. C. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.05.006 · Cited by 469
Chabaud, M., Fossiez, F., Taupin, J.-L., & Miossec, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.409 · Cited by 457
Foxp3 Inhibits RORγt-mediated IL-17A mRNA Transcription through Direct Interaction with RORγt*
Ichiyama, K., Yoshida, H., Wakabayashi, Y., Chinen, T., Saeki, K., Nakaya, M., Takaesu, G., Hori, S., Yoshimura, A., & Kobayashi, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801286200 · Cited by 435
Innate immunity in vertebrates: an overview
Riera Romo, M., Pérez‐Martínez, D., & Castillo Ferrer, C. (2016) · Immunology · doi:10.1111/imm.12597 · Cited by 435
The oral microbiota is modified by systemic diseases.
Graves, D. T., Corrêa, J. D., & Silva, T. A. (2019) · Journal of Dental Research · doi:10.1177/0022034518805739 · Cited by 423
Chu, C.-Q., Wittmer, S., & Dalton, D. K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.123 · Cited by 418
CD4 + T-cell subsets in inflammatory diseases: beyond the T h 1/T h 2 paradigm
Hirahara, K., & Nakayama, T. (2016) · International Immunology · doi:10.1093/intimm/dxw006 · Cited by 417
Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population.
de Pablo, P., Dietrich, T., & McAlindon, T. E. (2008) · PubMed · Cited by 404
TFH cells progressively differentiate to regulate the germinal center response
Weinstein, J. S., Herman, E. I., Lainez, B., Licona-Limón, P., Esplugues, E., Flavell, R., & Craft, J. (2016) · Nature Immunology · doi:10.1038/ni.3554 · Cited by 399
Genetics and epigenetics of rheumatoid arthritis
Viatte, S., Plant, D., & Raychaudhuri, S. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.237 · Cited by 396
Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice
Emamaullee, J. A., Davis, J., Merani, S., Toso, C., Elliott, J. F., Thiesen, A., & Shapiro, A. M. J. (2009) · Diabetes · doi:10.2337/db08-1113 · Cited by 378
Yu, J. J., Ruddy, M. J., Wong, G. C., Sfintescu, C., Baker, P. J., Smith, J. B., Evans, R. T., & Gaffen, S. L. (2007) · Blood · doi:10.1182/blood-2005-09-010116 · Cited by 372
Diagnosis and classification of psoriasis
Raychaudhuri, S. K., Maverakis, E., & Raychaudhuri, S. P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.008 · Cited by 370
Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364
Therapeutic monoclonal antibodies
Breedveld, F. (2000) · The Lancet · doi:10.1016/s0140-6736(00)01034-5 · Cited by 359
How the immune system works to protect the host from infection: A personal view
Janeway, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131202998 · Cited by 355
Fox, R. I., Michelson, P., Casiano, C. A., Hayashi, J., & Stern, M. (2000) · Clinics in Dermatology · doi:10.1016/s0738-081x(00)00135-8 · Cited by 355
Targeting Th17 cells in autoimmune diseases
Yang, J., Sundrud, M. S., Skepner, J., & Yamagata, T. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.07.006 · Cited by 348
Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
Levin, A. D., Wildenberg, M. E., & van den Brink, G. R. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw053 · Cited by 336
Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution
Kuek, A., Hazleman, B. L., & Östör, A. J. K. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2006.052688 · Cited by 335
Gaffen, S. L., & Hajishengallis, G. (2008) · Journal of Dental Research · doi:10.1177/154405910808700908 · Cited by 334
Seiderer, J., Elben, I., Diegelmann, J., Glas, J., Stallhofer, J., Tillack, C., Pfennig, S., Jürgens, M., Schmechel, S., Konrad, A., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20339 · Cited by 329
Stuart, P. E., Nair, R. P., Tsoi, L. C., Tejasvi, T., Das, S., Kang, H. M., Ellinghaus, E., Chandran, V., Callis-Duffin, K., Ike, R., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.10.019 · Cited by 319
Treatment of periodontal disease for glycaemic control in people with diabetes mellitus
Simpson, T. C., Weldon, J. C., Worthington, H. V., Needleman, I., Wild, S. H., Moles, D. R., Stevenson, B., Furness, S., & Iheozor-Ejiofor, Z. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004714.pub3 · Cited by 317
Katsifis, G. E., Rekka, S., Moutsopoulos, N. M., Pillemer, S., & Wahl, S. M. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090319 · Cited by 310
Zhang, G.-X., Gran, B., Yu, S., Li, J., Siglienti, I., Chen, X., Kamoun, M., & Rostami, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2153 · Cited by 305
Moutsopoulos, N. M., Konkel, J., Sarmadi, M., Eskan, M. A., Wild, T., Dutzan, N., Abusleme, L., Zenobia, C., Hosur, K. B., Abe, T., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007696 · Cited by 303
IL-17 Immunity in Human Type 1 Diabetes
Honkanen, J., Nieminen, J. K., Gao, R., Luopajarvi, K., Salo, H. M., Ilonen, J., Knip, M., Otonkoski, T., & Vaarala, O. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000788 · Cited by 297
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201601 · Cited by 293
Epidemiologic patterns of chronic and aggressive periodontitis
Demmer, R. T., & Papapanou, P. N. (2010) · Periodontology 2000 · doi:10.1111/j.1600-0757.2009.00326.x · Cited by 286
Th17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 282
Pappu, R., Ramirez-Carrozzi, V., & Sambandam, A. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03465.x · Cited by 281
Human T H 17 Cells Are Long-Lived Effector Memory Cells
Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J., Klimczak, A., Lange, A., & Zou, W. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002949 · Cited by 278
Mikuls, T. R., Payne, J. B., Reinhardt, R. A., Thiele, G. M., Maziarz, E., Cannella, A. C., Holers, V. M., Kuhn, K. A., & O'Dell, J. R. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.09.008 · Cited by 271
Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease
Cardoso, C. R., Garlet, G. P., Crippa, G. E., Rosa, A. L., Júnior, W. M., Rossi, M. A., & Silva, J. S. (2009) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2008.00463.x · Cited by 270
Saunte, D. M., Mrowietz, U., Puig, L., & Zachariae, C. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15015 · Cited by 270
MMPs, IL-1, and TNF are Regulated by IL-17 in Periodontitis
Beklen, A., Ainola, M., Hukkanen, M., Gürgan, C., Sorsa, T., & Konttinen, Y. T. (2007) · Journal of Dental Research · doi:10.1177/154405910708600409 · Cited by 259
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
Fasching, P., Stradner, M., Graninger, W., Dejaco, C., & Fessler, J. (2017) · Molecules · doi:10.3390/molecules22010134 · Cited by 254
Vernal, R., Dutzan, N., Chaparro, A., Puente, J., Antonieta Valenzuela, M., & Gamonal, J. (2005) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00684.x · Cited by 253
Dutzan, N., Abusleme, L., Bridgeman, H., Greenwell-Wild, T., Zangerle-Murray, T., Fife, M. E., Bouladoux, N., Linley, H., Brenchley, L., Wemyss, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.010 · Cited by 252 · cited 1×
“Th17 cells are also regularly maintained in the gingival tissues, suggesting a protective role in the oral barrier; however, the mechanism that maintains these cells in the tissue is yet to be clarified [66].”
BackgroundInvolvement of IL-17A in the pathogenesis of DSS-induced colitis in mice
Ito, R., Kita, M., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Iwakura, Y., Okanoue, T., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.019 · Cited by 251
The association of psoriasis with autoimmune diseases
Wu, J. J., Nguyen, T. U., Poon, K.-Y. T., & Herrinton, L. J. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.04.039 · Cited by 226
Th1/Th2 Cell Differentiation and Molecular Signals
Zhang, Y., Zhang, Y., Gu, W., & Sun, B. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-017-9487-9_2 · Cited by 223
Beikler, T., & Flemmig, T. F. (2011) · Periodontology 2000 · doi:10.1111/j.1600-0757.2010.00360.x · Cited by 211
Self-citationCytokines IL-17 and IL-22 in the host response to infection
Valeri, M., & Raffatellu, M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw111 · Cited by 202 · cited 1×
“Furthermore, the Th17-cytokine IL-22 was shown to contribute to IL-17-induced protective functions by enhancing the production of antimicrobial peptides and recruiting neutrophils [61].”
BackgroundAn inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
Grine, L., Dejager, L., Libert, C., & Vandenbroucke, R. E. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.10.009 · Cited by 200
Inflammatory bowel disease and oral health: systematic review and a meta‐analysis
Papageorgiou, S. N., Hagner, M., Nogueira, A. V. B., Franke, A., Jäger, A., & Deschner, J. (2017) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12698 · Cited by 195
Kalden, J. R., & Schulze-Koops, H. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.187 · Cited by 187
Blanco, F. J., Möricke, R., Dokoupilova, E., Codding, C., Neal, J., Andersson, M., Rohrer, S., & Richards, H. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40070 · Cited by 185
IL‐17: overview and role in oral immunity and microbiome
Abusleme, L., & Moutsopoulos, N. (2017) · Oral Diseases · doi:10.1111/odi.12598 · Cited by 183
Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1
Moutsopoulos, N. M., Zerbe, C. S., Wild, T., Dutzan, N., Brenchley, L., DiPasquale, G., Uzel, G., Axelrod, K. C., Lisco, A., Notarangelo, L. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612197 · Cited by 174
Mease, P. J. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000147 · Cited by 171
Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon
Mylonas, A., & Conrad, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02746 · Cited by 165
van Baarsen, L. G. M., Lebre, M. C., van der Coelen, D., Aarrass, S., Tang, M. W., Ramwadhdoebé, T. H., Gerlag, D. M., & Tak, P. P. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0426-z · Cited by 164
Dutzan, N., Gamonal, J., Silva, A., Sanz, M., & Vernal, R. (2009) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2009.01390.x · Cited by 162
Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis
Brito, F., Barros, F. C. D., Zaltman, C., Pugas Carvalho, A. T., De Vasconcellos Carneiro, A. J., Fischer, R. G., Gustafsson, A., & De Silva Figueredo, C. M. (2008) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2008.01231.x · Cited by 161
Elo, L. L., Järvenpää, H., Tuomela, S., Raghav, S. K., Ahlfors, H., Laurila, K., Gupta, B., Lund, R., Tahvanainen, J., Hawkins, R. D., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.011 · Cited by 159
The presence, function and regulation of IL‐17 and Th17 cells in periodontitis
Cheng, W., Hughes, F. J., & Taams, L. S. (2014) · Journal of Clinical Periodontology · doi:10.1111/jcpe.12238 · Cited by 159
Oral manifestations of systemic disease
CAWSON, R. A. (1982) · Journal of Dentistry · doi:10.1016/0300-5712(82)90073-2 · Cited by 156
Souto, A., Maneiro, J. R., Salgado, E., Carmona, L., & Gómez-Reino, J. J. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu172 · Cited by 155
Lubberts, E., Joosten, L. A. B., van de Loo, F. A. J., Schwarzenberger, P. O., Kolls, J., & van den Berg, W. B. (2002) · Inflammation Research · doi:10.1007/bf02684010 · Cited by 152
Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus
Martin, J. C., Baeten, D., & Josien, R. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.05.004 · Cited by 148
Sugihara, T., Kobori, A., Imaeda, H., Tsujikawa, T., Amagase, K., Takeuchi, K., Fujiyama, Y., & Andoh, A. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04093.x · Cited by 138
Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
Alzabin, S., Abraham, S., Taher, T. E. I., Palfreeman, A. C., Hull, D. N., McNamee, K., Jawad, A. S., Pathan, E., Kinderlerer, A. R., Taylor, P. C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201024 · Cited by 136
Lei, L., Zhao, C., Qin, F., He, Z., Wang, X., & Zhong, X.-N. (2016) · PubMed · Cited by 136
Oral Manifestations of Systemic Disease
Neville, B. W., Damm, D. D., Allen, C. M., & Chi, A. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55225-7.00017-8 · Cited by 136
T cells and IL-17 in lupus nephritis
Koga, T., Ichinose, K., & Tsokos, G. C. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.04.010 · Cited by 132
Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis
McGinley, A. M., Edwards, S. C., Raverdeau, M., & Mills, K. H. G. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.01.001 · Cited by 132
Rheumatoid arthritis in review: Clinical, anatomical, cellular and molecular points of view
Sharif, Κ., Sharif, A. M., Jumah, F., Oskouian, R. J., & Tubbs, R. S. (2017) · Clinical Anatomy · doi:10.1002/ca.22980 · Cited by 131
Hueber, W., Tomooka, B. H., Zhao, X., Kidd, B. A., Drijfhout, J. W., Fries, J. F., van Venrooij, W. J., METZGER, A. L., Genovese, M. C., & Robinson, W. H. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054924 · Cited by 130
Bilal, J., Berlinberg, A. J., Bhattacharjee, S., Trost, J. R., Riaz, I. B., & Kurtzman, D. J. B. (2018) · Journal of Dermatological Treatment · doi:10.1080/09546634.2017.1422591 · Cited by 128
Cellular and molecular perspectives in rheumatoid arthritis
Veale, D. J., Orr, C. K., & Fearon, U. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0633-1 · Cited by 126
Ghosh, S. K., Gensler, L. S., Yang, Z., et al. (2019) · Drug Safety · doi:10.1007/s40264-019-00797-3 · Cited by 122
Jethwa, H., & Bowness, P. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12670 · Cited by 119
Shifting the focus – the primary role of IL ‐23 in psoriasis and other inflammatory disorders
Gooderham, M., Papp, K. A., & Lynde, C. W. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14868 · Cited by 115
Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?
Lira‐Junior, R., & Figueredo, C. M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i35.7963 · Cited by 114
Matsuzaki, G., & Umemura, M. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12560 · Cited by 113
Periodontal Diseases and Dental Caries in Children with Type 1 Diabetes Mellitus
Novotná, M., Podzimek, Š., Broukal, Z., Lenčová, E., & Duskova, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/379626 · Cited by 112
Kunwar, S., Dahal, K. B., & Sharma, S. P. (2016) · Rheumatology International · doi:10.1007/s00296-016-3480-9 · Cited by 112
Lin, D., Li, L., Sun, Y., Wang, W., Wang, X., Yu, Y., Chen, X., & Xu, Y. (2014) · Immunology · doi:10.1111/imm.12395 · Cited by 110
Kwok, S., Cho, M., Her, Y., Oh, H.-J., Park, M.-K., Lee, S.-Y., Woo, Y. J., Ju, J. H., Park, K.-S., Kim, H., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3780 · Cited by 110
Historical Development of Monoclonal Antibody Therapeutics
Nissim, A., & Chernajovsky, Y. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_1 · Cited by 109
Kurebayashi, Y., Nagai, S., Ikejiri, A., & Koyasu, S. (2013) · Genes to Cells · doi:10.1111/gtc.12039 · Cited by 102
Awang, R. A., Lappin, D. F., MacPherson, A., Riggio, M. P., Robertson, D. P., Hodge, P. J., Ramage, G., Culshaw, S., Preshaw, P. M., Taylor, J. J., et al. (2014) · Inflammation Research · doi:10.1007/s00011-014-0776-7 · Cited by 98
Signs of the presence of Th17 cells in chronic periodontal disease
Adibrad, M., Deyhimi, P., Ganjalıkhani-Hakemi, M., Behfarnia, P., Shahabuei, M., & Rafiee, L. (2012) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2011.01464.x · Cited by 97
IL-17 in Sera from Patients with Aggressive Periodontitis
Schenkein, H. A., Koertge, T. E., Brooks, C. N., Sabatini, R., Purkall, D. E., & Tew, J. G. (2010) · Journal of Dental Research · doi:10.1177/0022034510369297 · Cited by 93
Adams, S., & Bornemann, P. H. (2013) · PubMed · Cited by 91
Paola, R. D., Mazzon, E., Muià, C., Crisafulli, C., Terrana, D., Greco, S., Britti, D., Santori, D., Oteri, G., Cordasco, G., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706979 · Cited by 89
Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis
Miyazaki, Y., Nakayamada, S., Kubo, S., Nakano, K., Iwata, S., Miyagawa, I., Ma, X., Trimova, G., Sakata, K., & Tanaka, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02901 · Cited by 87
Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis
Raychaudhuri, S. K., Saxena, A., & Raychaudhuri, S. P. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-2961-7 · Cited by 84
Association between multiple sclerosis and chronic periodontitis: a population‐based pilot study
Sheu, J., & Lin, H. (2013) · European Journal of Neurology · doi:10.1111/ene.12103 · Cited by 84
Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy
Fabbri, C., Fuller, R., Bonfá, E., Guedes, L. K. N., D'Alleva, P. S. R., & Borba, E. F. (2014) · Clinical Rheumatology · doi:10.1007/s10067-013-2473-2 · Cited by 84
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases
Guo, B. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000400 · Cited by 84
Ramamoorthi, G., & Rasool, M. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2016.1269175 · Cited by 83
Role of the IL-23/IL-17 axis in Crohn's disease.
Siakavellas, S. I., & Bamias, G. (2012) · PubMed · Cited by 82
Risk of periodontitis in patients with psoriasis and psoriatic arthritis
Egeberg, A., Mallbris, L., Gislason, G., Hansen, P. R., & Mrowietz, U. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13814 · Cited by 82
Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases
Nibali, L., Henderson, B. E., Sadiq, S. T., & Donos, N. (2014) · Journal of Oral Microbiology · doi:10.3402/jom.v6.22962 · Cited by 80
Advances in the understanding and treatment of systemic complications in Sjögren's syndrome
Brito‐Zerón, P., & Ramos‐Casals, M. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000096 · Cited by 79
The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
Yost, J. M., & Gudjonsson, J. E. (2009) · F1000 Medicine Reports · doi:10.3410/m1-30 · Cited by 78
Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs
Khan, D., & Ahmed, S. A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00236 · Cited by 77
Autoimmunity and autoimmune co‐morbidities in psoriasis
Furue, K., Ito, T., Tsuji, G., Kadono, T., Nakahara, T., & Furue, M. (2018) · Immunology · doi:10.1111/imm.12891 · Cited by 76
IL-17/Th17 mediated synovial inflammation is IL-22 independent
van Hamburg, J. P., Corneth, O. B. J., Paulissen, S. M. J., Davelaar, N., Asmawidjaja, P. S., Mus, A. M. C., & Lubberts, E. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202373 · Cited by 75
The effects of chronic periodontitis and its treatment on the subsequent risk of psoriasis
Keller, J. J., & Lin, H. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11126.x · Cited by 73
IL-17 and IL-22 Promote Keratinocyte Stemness in the Germinative Compartment in Psoriasis
Ekman, A., Bivik, C. A., Rundquist, I., & Enerbäck, C. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.014 · Cited by 73
Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn's disease
Tan, C. X. W., Brand, H. S., de Boer, N. K. H., & Forouzanfar, T. (2016) · BDJ · doi:10.1038/sj.bdj.2016.954 · Cited by 72
Segaert, S., & Hermans, C. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0296-7 · Cited by 71
Li, Y., Zhang, S., Ma, X., Xue, Y.-L., Gao, C., & Li, X. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.09.003 · Cited by 63
Psoriasis is not an autoimmune disease?
Fry, L., Baker, B. S., Powles, A. V., & Engstrand, L. G. (2014) · Experimental Dermatology · doi:10.1111/exd.12572 · Cited by 62
Emmi, G., Silvestri, E., Bella, C. D., Grassi, A., Benagiano, M., Cianchi, F., Squatrito, D., Cantarini, L., Emmi, L., Selmi, C. F., et al. (2016) · Medicine · doi:10.1097/md.0000000000005516 · Cited by 61
Risk Factors and Primary Prevention Trials for Type 1 Diabetes
Wu, Y., Ding, Y., Gao, J. J., Tanaka, Y., & Zhang, W. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6610 · Cited by 60
Díaz‐Zúñiga, J., Melgar‐Rodríguez, S., Rojas, L., Álvarez, C., Monasterio, G., Carvajal, P., & Vernal, R. (2017) · Journal of Periodontal Research · doi:10.1111/jre.12461 · Cited by 59
Th17 and Treg Cells in Bone Related Diseases
Wang, M., Tian, T., Yu, S., He, N., & Ma, D. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/203705 · Cited by 57
Ling, Y., & Puel, A. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(14)70016-x · Cited by 57
Association of chronic periodontitis and psoriasis: periodontal status with severity of psoriasis
Sharma, A., Raman, A., & Pradeep, A. (2014) · Oral Diseases · doi:10.1111/odi.12271 · Cited by 50
T Helper 17 Cells in Primary Sjögren’s Syndrome
Matsui, K., & Sano, H. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6070065 · Cited by 50
Lazaridou, E., Tsikrikoni, A., Fotiadou, C., Kyrmanidou, E., Vakirlis, E., Giannopoulou, C., Apalla, Z., & Ioannides, D. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04615.x · Cited by 49
Gümüş, P., Buduneli, E., Bıyıkoğlu, B., Aksu, K., Saraç, F., Nile, C. J., Lappin, D. F., & Buduneli, N. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.120595 · Cited by 49
Harnessing the Therapeutic Potential of Th17 Cells
Byström, J., Taher, T. E. I., Muhyaddin, M. S., Clanchy, F. I. L., Mangat, P., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/205156 · Cited by 48
Hillen, M. R., Ververs, F. A., Kruize, A. A., & van Roon, J. A. G. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.878650 · Cited by 48
Kluger, M., Nosko, A., Ramcke, T., Goerke, B., Meyer, M. C., Wegscheid, C., Luig, M., Tiegs, G., Stahl, R. A. K., & Steinmetz, O. M. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12905 · Cited by 48
Song, L., Zhou, R., Huang, S., Zhou, F., Xu, S., Wang, W., Yi, F., Wang, X., & Xia, B. (2013) · Mediators of Inflammation · doi:10.1155/2013/425915 · Cited by 47
Cytokine Imbalance as a Common Mechanism in Both Psoriasis and Rheumatoid Arthritis
Tan, Y., Qiu, Q., Lu, C. C., Niu, X., Bai, Y., Jiang, C., Wang, Y., Zhou, Y., Lü, A., & Xiao, C. (2017) · Mediators of Inflammation · doi:10.1155/2017/2405291 · Cited by 44
Lugonja, B., Yeo, L., Milward, M. R., Smith, D. L., Dietrich, T., Chapple, I., Rauz, S., Williams, G. P., Barone, F., de Pablo, P., et al. (2015) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12485 · Cited by 43
Chi, Y.-C., Chen, J.-L., Wang, L., Chang, K., Wu, C.-L., Lin, S., Keller, J. J., & Bai, C. (2018) · International Journal of Colorectal Disease · doi:10.1007/s00384-018-3117-4 · Cited by 42
Pollard, R., Abdulahad, W. H., Bootsma, H., Meiners, P. M., Spijkervet, F. K. L., Huitema, M. G., Burgerhof, J. G. M., Vissink, A., & Kroese, F. G. M. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203447 · Cited by 40
Saitō, M., Otsuka, K., Ushio, A., Yamada, A., Arakaki, R., Kudo, Y., & Ishimaru, N. (2017) · Current Rheumatology Reviews · doi:10.2174/1573397113666170125122858 · Cited by 40
Su, N., Huang, J., Hu, C.-J., et al. (2017) · PubMed · doi:10.7717/peerj.4064 · Cited by 40
Guselkumab for the Treatment of Psoriasis
Machado, Á., & Torres, T. R. (2018) · BioDrugs · doi:10.1007/s40259-018-0265-6 · Cited by 40
Role of bacteria in leukocyte adhesion deficiency-associated periodontitis
Hajishengallis, G., & Moutsopoulos, N. M. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.09.003 · Cited by 39
Smoking as a Permissive Factor of Periodontal Disease in Psoriasis
Antal, M. Á., Braunitzer, G., Mattheos, N., Gyulai, R., & Nagy, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092333 · Cited by 39
Relationship between sjögren syndrome and periodontal status: A systematic review
Soares, L. D. G., Rocha, R., Pinto, E. B., Galvão, E. L., de Oliveira, D. W. D., & Falci, S. G. M. (2017) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2017.11.018 · Cited by 39
Hajishengallis, G., & Moutsopoulos, N. M. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.929944 · Cited by 38
Brodalumab for the treatment of plaque psoriasis: up-to-date
Beck, K. M., & Koo, J. Y. M. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1579794 · Cited by 36
Genovese, M. C., Braun, D. K., Erickson, J., Berclaz, P., Banerjee, S., Heffernan, M. P., & Carlier, H. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140831 · Cited by 35
Periodontitis as another comorbidity associated with psoriasis: A case‐control study
Mendes, V. S., Cota, L. O. M., Costa, A. A., Oliveira, A. M. S. D., & Costa, F. O. (2018) · Journal of Periodontology · doi:10.1002/jper.18-0394 · Cited by 35
Gudjonsson, J. E., & Krueger, G. G. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.364 · Cited by 34
Thilagar, S., Theyagarajan, R., Sudhakar, U., Suresh, S., Saketharaman, P., & Ahamed, N. (2018) · Journal of Indian Society of Periodontology · doi:10.4103/jisp.jisp_362_17 · Cited by 33
Corrêa, M. G., Sacchetti, S., Ribeiro, F. V., Pimentel, S. P., Casarin, R. C. V., Cirano, F. R., & Casati, M. Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174442 · Cited by 29
Diseases that may benefit from manipulating the Th17 pathway
Miossec, P. (2009) · European Journal of Immunology · doi:10.1002/eji.200839088 · Cited by 28
Jung, S. M., Lee, J. H., Lee, J., Kim, E.-J., Kwok, S., Cho, M.-L., Park, K. S., Kim, H.-Y., & Park, S.-H. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-eular.214 · Cited by 28
Wu, Y., Lin, C., Chao, W., Liao, T., Chen, D., & Chen, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187075 · Cited by 28
Mendonça, S. M. S., Corrêa, J. D., de Souza, A. F., Travassos, D. V., Calderaro, D. C., Rocha, N. P., Vieira, É. L. M., Teixeira, A. L., Ferreira, G. A., & Silva, T. A. (2019) · PubMed · Cited by 26
Marwaha, A., Panagiotopoulos, C., Biggs, C. M., Staiger, S., Bel, K. L. D., Hirschfeld, A. F., Priatel, J. J., Turvey, S. E., & Tan, R. (2017) · Genes and Immunity · doi:10.1038/gene.2016.44 · Cited by 25
Review of IL-17 inhibitors for psoriasis
Amin, M., Darji, K., No, D. J., Bhutani, T., & Wu, J. J. (2017) · Journal of Dermatological Treatment · doi:10.1080/09546634.2017.1395796 · Cited by 24
Life before seventeen: cloning of the IL-17 receptor
Gaffen, S. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102576 · Cited by 22 · cited 1×
“The IL-17 receptor (IL-17R) lacks a homologous structure to other proteins; therefore, IL-17 cytokines are classified as a distinct family [53].”
BackgroundIL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease
Mitra, A., Raychaudhuri, S., & Raychaudhuri, S. P. (2014) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(14)70015-8 · Cited by 22
No association between multiple sclerosis and periodontitis after adjusting for smoking habits
Gustavsen, M. W., Celius, E. G., Moen, S. M., Bjølgerud, A., Berg‐Hansen, P., Nygaard, G. O., Sandvik, L., Lie, B. A., & Harbo, H. F. (2014) · European Journal of Neurology · doi:10.1111/ene.12520 · Cited by 20
Expression levels of th-2 and th-17 characteristic genes in healthy tissue versus periodontitis.
Behfarnia, P., Birang, R., Pishva, S. S., Ganjalıkhani-Hakemi, M., & Khorasani, M. M. (2013) · Europe PMC (PubMed Central) · Cited by 20
Cited by
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,946
COVID-19: A promising cure for the global panic
Vellingiri, B., Jayaramayya, K., Iyer, M., Narayanasamy, A., Govindasamy, V., Giridharan, B., Ganesan, S., Venugopal, A., Venkatesan, D., Ganesan, H., et al. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138277 · Cited by 636
Periodontal Inflammation and Systemic Diseases: An Overview
Martínez-García, M., & Hernández-Lemus, E. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.709438 · Cited by 512
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Zhao, M., Chu, J., Feng, S., Guo, C., Xue, B., He, K., & Li, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114985 · Cited by 458
Periodontal Disease: The Good, The Bad, and The Unknown
Sedghi, L. M., Bacino, M., & Kapila, Y. L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.766944 · Cited by 362
Metadata
- Authors
- Kaymaz, K., & Beikler, T.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-07-10
- Volume
- 20
- Issue
- 14
- Pages
- 3394
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2957836220
- Cited by
- 534
- References
- 205
- FWCI
- 16.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.